Sarecycline
In clinical developmentAlso known as Seysara, Sareciclina, Sarécycline, Sarecyclinum.
Recent clinical, regulatory, research and industry developments relating to this drug.
The Effects of Sarecycline Versus Doxycycline on the Gut Microbiome and Skin Microbiome in Acne.
Guidelines of care for the management of acne vulgaris.
A Pilot Study on the Use of Seysara for Rosacea
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
The Effects of Sarecycline Versus Doxycycline on the Gut Microbiome and Skin Microbiome in Acne.
A Pilot Study on the Use of Seysara for Rosacea
Recent completions
Trials that read out recently, adding to the completed evidence base.
A Pilot Study on the Use of Seysara for Rosacea
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Journal of the American Academy of Dermatology1
- Barbieri JS1
- Cheng CE1
- Cook-Bolden F1
- Desai SR1
- Druby KM1
- Freeman EE1
- Han JM1
- Keri JE1
- American Academy of Dermatology1
- Beth Israel Deaconess Medical Center1
- Brigham and Women's Hospital1
- Emory University School of Medicine1
- Massachusetts General Hospital1
- Mayo Clinic1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
Studied across the same disease area as Sarecycline in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials